- Home
- SURG vs ESLA Comparison
SURG vs ESLA Comparison
Compare SURG & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ESLA
- Stock Information
- Founded
- SURG 2006
- ESLA 2021
- Country
- SURG United States
- ESLA United States
- Employees
- SURG N/A
- ESLA N/A
- Industry
- SURG Advertising
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SURG Consumer Discretionary
- ESLA Health Care
- Exchange
- SURG Nasdaq
- ESLA Nasdaq
- Market Cap
- SURG 56.8M
- ESLA 48.9M
- IPO Year
- SURG N/A
- ESLA N/A
- Fundamental
- Price
- SURG $2.49
- ESLA $2.29
- Analyst Decision
- SURG Strong Buy
- ESLA Strong Buy
- Analyst Count
- SURG 1
- ESLA 1
- Target Price
- SURG $9.50
- ESLA $16.00
- AVG Volume (30 Days)
- SURG 103.8K
- ESLA 461.1K
- Earning Date
- SURG 11-12-2025
- ESLA 11-20-2025
- Dividend Yield
- SURG N/A
- ESLA N/A
- EPS Growth
- SURG N/A
- ESLA N/A
- EPS
- SURG N/A
- ESLA N/A
- Revenue
- SURG $36,461,935.00
- ESLA N/A
- Revenue This Year
- SURG $20.20
- ESLA N/A
- Revenue Next Year
- SURG $121.54
- ESLA N/A
- P/E Ratio
- SURG N/A
- ESLA N/A
- Revenue Growth
- SURG N/A
- ESLA N/A
- 52 Week Low
- SURG $1.05
- ESLA $0.70
- 52 Week High
- SURG $3.47
- ESLA $3.15
- Technical
- Relative Strength Index (RSI)
- SURG 37.20
- ESLA 56.58
- Support Level
- SURG $2.57
- ESLA $2.31
- Resistance Level
- SURG $2.95
- ESLA $2.80
- Average True Range (ATR)
- SURG 0.17
- ESLA 0.41
- MACD
- SURG -0.03
- ESLA 0.03
- Stochastic Oscillator
- SURG 7.28
- ESLA 47.24
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.